Equity MRK
Friday, May 25, 2018   
Adani Ports  379.90    (2.34%)
 
Asian Paints  1289.65    (-0.04%)
 
Axis Bank  538.45    (0.75%)
 
Bajaj Auto  2759.85    (0.85%)
 
Bharti Airtel  376.65    (1.40%)
 
Coal India  276.05    (-1.36%)
 
Dr Reddy's Lab...  1971.90    (-0.08%)
 
H D F C  1820.00    (0.77%)
 
HDFC Bank  2011.65    (1.30%)
 
Hero Motocorp  3550.70    (1.85%)
 
Hind. Unilever  1575.70    (0.90%)
 
ICICI Bank  296.50    (-0.25%)
 
IndusInd Bank  1914.75    (2.33%)
 
Infosys  1228.80    (0.57%)
 
ITC  271.95    (-1.04%)
 
Kotak Mah. Ban...  1298.25    (1.78%)
 
Larsen & Toubr...  1343.80    (0.38%)
 
M & M  857.30    (1.55%)
 
Maruti Suzuki  8546.85    (1.63%)
 
NTPC  165.10    (0.03%)
 
O N G C  175.35    (4.59%)
 
Power Grid Cor...  211.95    (0.09%)
 
Reliance Inds.  921.75    (0.62%)
 
St Bk of India  267.00    (-0.56%)
 
Sun Pharma.Ind...  466.55    (0.97%)
 
Tata Motors  294.20    (1.82%)
 
Tata Motors-DV...  171.75    (2.05%)
 
Tata Steel  567.20    (3.43%)
 
TCS  3589.45    (-0.43%)
 
Wipro  264.95    (0.28%)
 
Yes Bank  339.45    (2.71%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Corporate News
Granules India gets ANDA approval for Methylergonovine 0.2 mg Tablets
(08:55, 17 May 2018)
Granules India announced that the USFDA has approved its Abbreviated New Drug Applications (ANDA) for Methylergonovine 0.2 mg Tablets. The AN DA was filed by Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India. The approved ANDA is the bioequivalent to the reference listed drug product (RLD), Methergine 0.2 MG.

Methylergonovine is a semi—synthetic ergot alkaloid used for the prevention and control of postpartum haemorrhage.

Powered by Capital Market - Live News